help button home button Am J Pathol ASIP WHAT IS IT?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murphy, D.
Right arrow Articles by Hogan, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murphy, D.
Right arrow Articles by Hogan, B.

American Journal of Pathology, Vol 129, 552-566, Copyright © 1987 by American Society for Investigative Pathology


REGULAR ARTICLES

Mice transgenic for a vasopressin-SV40 hybrid oncogene develop tumors of the endocrine pancreas and the anterior pituitary. A possible model for human multiple endocrine neoplasia type 1

D Murphy, A Bishop, G Rindi, MN Murphy, GW Stamp, J Hanson, JM Polak and B Hogan
Laboratory of Molecular Embryology, National Institute for Medical Research, London, England.

The authors have used transgenic mice to study the activity of a hybrid oncogene made up of 1.25 kb of 5' upstream sequences, derived from the bovine vasopressin gene, promoting the expression of the large T- antigen coding sequences of the early region of simian virus 40. Rather than promoting tumorigenesis in vasopressinergic cells of the hypothalamus, expression and activity of the hybrid oncogene, and consequent tumor formation, were confined to insulin-producing beta cells of the endocrine pancreas and to cells in the anterior pituitary. These observations suggest that the specificity of vasopressin gene expression normally results from an interaction between several regulatory elements, some of which are absent from the hybrid oncogene. The possible relationship between the endocrine tumor syndrome found in the vasopressin-SV40 transgenic mice and familial human multiple endocrine neoplasia is discussed.


This article has been cited by other articles:


Home page
Physiol. Rev.Home page
J. P. H. Burbach, S. M. Luckman, D. Murphy, and H. Gainer
Gene Regulation in the Magnocellular Hypothalamo-Neurohypophysial System
Physiol Rev, July 1, 2001; 81(3): 1197 - 1267.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. J. Haas, Y. P. Dragan, H. Hikita, R. Shimel, K. Takimoto, S. Heath, J. Vaughan, and H. C. Pitot
Transgene Expression and Repression in Transgenic Rats Bearing the Phosphoenolpyruvate Carboxykinase-Simian Virus 40 T Antigen or the Phosphoenolpyruvate Carboxykinase-Transforming Growth Factor-{alpha} Constructs
Am. J. Pathol., July 1, 1999; 155(1): 183 - 192.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
J. Adams and S Cory
Transgenic models of tumor development
Science, November 22, 1991; 254(5035): 1161 - 1167.
[Abstract] [PDF]


Home page
ScienceHome page
R Jaenisch
Transgenic animals
Science, June 10, 1988; 240(4858): 1468 - 1474.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by the American Society for Investigative Pathology.